Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence.
Rostène
W
W
INSERM U.339, Hôpital Saint-Antoine, Paris, France.
Brouard
A
A
Dana
C
C
Masuo
Y
Y
Agid
F
F
Vial
M
M
Lhiaubet
A M
AM
Pelaprat
D
D
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D001923:Brain Chemistry; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D000882:Haplorhini; D009474:Neurons / Q000737:chemistry / Q000378:metabolism; D009496:Neurotensin / Q000737:chemistry / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013681:Tegmentum Mesencephali / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D018492:Dopamine Antagonists; D009496:Neurotensin; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine